LifeTech Scientific Corporation (HKG:1302)

-7.43% (1Y)

Market Cap	7.50B
Revenue (ttm)	1.38B
Net Income (ttm)	267.16M
Shares Out	4.63B
EPS (ttm)	0.06
PE Ratio	27.04
Forward PE	16.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,517,571
Average Volume	24,247,302
Open	1.620
Previous Close	1.610
Day's Range	1.550 - 1.640
52-Week Range	1.240 - 2.070
Beta	0.92
RSI	53.14
Earnings Date	Mar 28, 2025

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,448
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2023, LifeTech Scientific's revenue was 1.27 billion, an increase of 15.48% compared to the previous year's 1.10 billion. Earnings were 263.24 million, a decrease of -19.09%.

Financial numbers in CNY